- Home
- FLYX vs IMA Comparison
FLYX vs IMA Comparison
Compare FLYX & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- IMA
- Stock Information
- Founded
- FLYX 2015
- IMA 2019
- Country
- FLYX United States
- IMA United States
- Employees
- FLYX N/A
- IMA N/A
- Industry
- FLYX Blank Checks
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLYX Finance
- IMA Health Care
- Exchange
- FLYX Nasdaq
- IMA Nasdaq
- Market Cap
- FLYX 79.8M
- IMA 92.2M
- IPO Year
- FLYX N/A
- IMA N/A
- Fundamental
- Price
- FLYX $3.22
- IMA $8.22
- Analyst Decision
- FLYX
- IMA Buy
- Analyst Count
- FLYX 0
- IMA 1
- Target Price
- FLYX N/A
- IMA $30.00
- AVG Volume (30 Days)
- FLYX 25.5K
- IMA 66.5K
- Earning Date
- FLYX 11-13-2025
- IMA 11-13-2025
- Dividend Yield
- FLYX N/A
- IMA N/A
- EPS Growth
- FLYX N/A
- IMA N/A
- EPS
- FLYX N/A
- IMA N/A
- Revenue
- FLYX $347,746,000.00
- IMA $4,300,000.00
- Revenue This Year
- FLYX $28.47
- IMA N/A
- Revenue Next Year
- FLYX $22.44
- IMA N/A
- P/E Ratio
- FLYX N/A
- IMA N/A
- Revenue Growth
- FLYX 17.09
- IMA N/A
- 52 Week Low
- FLYX $1.90
- IMA $7.24
- 52 Week High
- FLYX $6.90
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- FLYX 37.83
- IMA N/A
- Support Level
- FLYX $3.51
- IMA N/A
- Resistance Level
- FLYX $4.00
- IMA N/A
- Average True Range (ATR)
- FLYX 0.37
- IMA 0.00
- MACD
- FLYX -0.02
- IMA 0.00
- Stochastic Oscillator
- FLYX 43.57
- IMA 0.00
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.